Groupe Bruxelles Lambert SA (FRA:EAI)

Market Cap	9.04B
Revenue (ttm)	6.45B
Net Income (ttm)	-102.70M
Shares Out	n/a
EPS (ttm)	-0.79
PE Ratio	n/a
Forward PE	26.12
Dividend	3.50 (4.57%)
Ex-Dividend Date	May 9, 2025

Volume	n/a
Average Volume	265
Open	74.55
Previous Close	75.85
Day's Range	74.55 - 74.55
52-Week Range	63.10 - 76.65
Beta	n/a
RSI	53.30
Earnings Date	Jul 31, 2025

About Intra-Cellular Therapies

Groupe Bruxelles Lambert SA invests in a portfolio of industrial, consumer goods, and business service companies operating in various sectors in Belgium, other European countries, North America, and internationally. The company operates through six segments: Holding, Imerys, Canyon, Affidea, Sanoptis, and GBL Capital and Sienna Investment Managers. Groupe Bruxelles Lambert SA was incorporated in 1902 and is based in Brussels, Belgium.

• Industry: Investors, not elsewhere classified
• Founded: 1902
• Employees: 69
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: EAI

Financial Performance

In 2024, Groupe Bruxelles Lambert's revenue was 6.68 billion, a decrease of -0.98% compared to the previous year's 6.75 billion. Earnings were 132.30 million, a decrease of -92.32%.